Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | +2.70% | -0.87% | +4.59% |
Business Summary
Number of employees: 72
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products
100.0
%
| 15 | 100.0 % | 9 | 100.0 % | -39.16% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 15 | 100.0 % | 9 | 100.0 % | -39.16% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 52 | 18-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 22-11-13 |
Chief Operating Officer | - | 09-12-31 | |
Gary S. Hogge
CTO | Chief Tech/Sci/R&D Officer | 56 | 18-01-31 |
Ioana C. Hone
IRC | Investor Relations Contact | - | - |
George Samuel
LAW | General Counsel | - | 21-08-31 |
Derek Kelaita
PRN | Corporate Officer/Principal | - | 19-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 09-06-30 |
Brian Culley
CEO | Chief Executive Officer | 52 | 18-09-16 |
Director/Board Member | 66 | 14-04-10 | |
Alfred Kingsley
CHM | Chairman | 81 | 09-06-30 |
Don Bailey
BRD | Director/Board Member | 78 | 19-03-07 |
Angus Russell
BRD | Director/Board Member | 68 | 14-12-08 |
Michael Mulroy
BRD | Director/Board Member | 58 | 14-10-03 |
Director/Board Member | 67 | 21-05-03 | |
Dipti Amin
BRD | Director/Board Member | 60 | 21-04-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 188,533,536 | 180,745,360 ( 95.87 %) | 0 | 95.87 % |
Company contact information
Lineage Cell Therapeutics, Inc.
2173 Salk Avenue Suite 200
92008-7354, Carlsbad
+442 287 8990
http://www.lineagecell.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.59% | 215M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- LCTX Stock
- Company Lineage Cell Therapeutics, Inc.